M&A Deal Summary

Agilent Acquires BioSystem Development

On December 21, 2011, Agilent acquired test/measurement equipment company BioSystem Development

Acquisition Highlights
  • This is Agilent’s 6th transaction in the Test/Measurement Equipment sector.
  • This is Agilent’s 14th transaction in the United States.
  • This is Agilent’s 1st transaction in Wisconsin.

M&A Deal Summary
Date 2011-12-21
Target BioSystem Development
Sector Test/Measurement Equipment
Buyer(s) Agilent
Deal Type Add-on Acquisition

Target

BioSystem Development

Madison, Wisconsin, United States
BioSystem Development develops and manufactures the AssayMAP Microchromatography platform to meet the analytical needs of the life sciences industry.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Agilent

Santa Clara, California, United States
Category Company
Founded 1999
Sector Test/Measurement Equipment
Employees17,600
Revenue 6.8B USD (2023)
DESCRIPTION
Entrance to Agilent's headquarters in Santa Clara, California.
Entrance to Agilent's headquarters in Santa Clara, California.

Agilent is a producer of solutions that includes instruments, software, services, and consumables for the entire laboratory workflow. Agilent's life sciences and applied markets business provide application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Agilent was founded in 1999 and is based in Santa Clara, California.

DEAL STATS #
Overall 16 of 38
Sector (Test/Measurement Equipment) 6 of 9
Type (Add-on Acquisition) 13 of 35
State (Wisconsin) 1 of 1
Country (United States) 14 of 28
Year (2011) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-01 Halo Genomics AB

Uppsala, Sweden

Halo Genomics is a provider of technology for the next-generation DNA sequencing market. Halo Genomics' technology addresses sequence-selective sample preparation in next-generation sequencing. The company's HaloPlex technology combines the speed and specificity of polymerase chain reaction-based systems with the scalability and capture-size flexibility of solution-based hybridization formats, thus eliminating the need for library preparation.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-02-21 Accelicon Technologies

Cupertino, California, United States

Accelicon provides device-level modeling and validation software for the electronics industry. Solutions include MBP for device-level extraction and model generation, MQA for device-level model validation and AMA for advanced model analysis including layout effects.

Buy -
Mergr

Product

Company

Legal